Hormone therapy for prostate cancer does have limitations. Right now, it's usually used only in men whosecancerhas recurred or spread elsewhere in the body. But even in cases where removing or killing thecancerisn't possible, hormone therapy can help slow downcancergrowth. Though it isn't ...
Hormone therapy with leuprolide acetate (Lupron) is frequently used to treat prostate cancer, a common malignancy expected to be diagnosed in >180,000 men in the United States this year. In addition, testosterone supplementation is frequently recommended for adult men with reduced libido or ...
Hormone therapy remains the primary treatment of metastatic prostate cancer. It also serves a role for treatment of intermediate-and high-risk disease that are treated with radiation, and based on data showing synergy and improved survival with multimodality therapy, hormone therapy may be given ...
Although substantial decreases in prostate specific antigen level and prostatic volume occurred, only 2 patients experienced pathological downstaging of disease. We conclude that luteinizing hormone-releasing hormone therapy for downstaging of clinical stage C is of limited value. 展开 ...
Want to thank TFD for its existence?Tell a friend about us, add a link to this page, or visitthe webmaster's page for free fun content. Link to this page: Facebook Twitter ▲ luteinized ovarian cyst luteinized unruptured follicle
Criteria for Initial Approval Aetna considers degarelix (Firmagon) medically necessary for the treatment of prostate cancer. Aetna considers all other indications as experimental, investigational, or unproven. Continuation of Therapy Aetna considers continuation of degarelix (Firmagon) therapy medically necessar...
Leuprolide (Lupron) Goserelin (Zoladex) Central Precocious Puberty Nafarelin Acetate (Synarel) Leuprolide (Lupron) Histrelin (Vantas) Triptorelin (Trelstar) Uterine Fibroids Leuprolide (Lupron) Prostate Cancer (Men with regionally advanced or metastatic cancer) Leuprolide (Lupron) Goserelin (Zoladex) Hist...
Failure to achieve castrate levels of testosterone during luteinizing hormone-releasing hormone agonist therapy: The case for monitoring serum testosterone and a treatment decision algorithm. Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian ...
Santen RJ. Clinical Review 37: Endocrine treatment of prostate cancer. J Clin Endocrinol Metab 1992; 75: 685–9 ArticlePubMedCASGoogle Scholar Labrie F, Belanger A, Simard J, et al. Combination therapy for prostate cancer: endocrine and biologic basis of its choice as new standard first-line...
Hormone therapy with leuprolide acetate (Lupron) is frequently used to treat prostate cancer, a common malignancy expected to be diagnosed in >180,000 men in the United States this year. In addition, testosterone supplementation is frequently recommended for adult men with reduced libido or ...